ProfileGDS5678 / 1422559_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 96% 96% 96% 96% 96% 96% 96% 96% 96% 96% 96% 96% 96% 96% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 18.7349196
GSM967853U87-EV human glioblastoma xenograft - Control 28.9480896
GSM967854U87-EV human glioblastoma xenograft - Control 38.9055896
GSM967855U87-EV human glioblastoma xenograft - Control 49.0616196
GSM967856U87-EV human glioblastoma xenograft - Control 58.8098896
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 18.7992796
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 28.6006896
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 38.8329996
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 48.799996
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 18.9606296
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 28.9734496
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 39.0145296
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 49.0084796
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 59.0200296